EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Prolonged SARS-CoV-2 Infection and Organizing Pneumonia in a Patient with Follicular Lymphoma, Treated with Obinutuzumab—Challenging Recognition and Treatment

E Łyżwa, M Sobiecka iD, K Lewandowska iD, I Siemion-Szcześniak, I Barańska, M Klatt, R Langfort, M Szturmowicz, W Tomkowski

Viruses · 2023

DOI: 10.3390/v15030693 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Viruses, 2023. Verfasst von E Łyżwa und 8 weiteren Autor:innen. Beteiligte Einrichtung: 1st Department of Lung Diseases, National Research Institute of Tuberculosis and Lung Diseases, 01-138 Warsaw, Poland. Hauptthemen laut MEDLINE: COVID-19, Lymphoma, Follicular, Organizing Pneumonia, Pneumonia. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causing coronavirus disease 2019 (COVID-19) led to a pandemic outbreak in 2019. COVID-19’s course and its treatment in immunocompromised patients are uncertain. Furthermore, there is a possibility of protracted SARS-CoV-2 infection and the need for repeated antiviral treatment. Monoclonal antibodies against CD20, which are used, among other things, in the therapy of chronic lymphocytic leukaemia and follicular lymphoma, can induct immunosuppression. We present a case report of a patient with follicular lymphoma, treated with obinutuzumab, who was diagnosed with prolonged, ongoing SARS-CoV-2 infection and related organizing pneumonia. The recognition and the treatment were challenging which makes this case noteworthy. Antiviral therapy with several medications was administrated to our patient and their temporary, positive effect was observed. Moreover, high-dose intravenous immunoglobulin was applied, because slowly decreasing IgM and IgG levels were observed. The patient also received standard treatment of organizing pneumonia. We believe that such a complex approach can create an opportunity for recovery. Physicians should be conscious of the course and treatment possibilities facing similar cases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Lymphoma, FollicularOrganizing PneumoniaPneumoniaHumansSARS-CoV-2Antibodies, Monoclonal, Humanized

Stichwörter der Autor:innen

COVID-19obinutuzumaborganizing pneumoniaprolonged SARS-CoV-2 infection

Substanzen

obinutuzumabAntibodies, Monoclonal, Humanized

Autor:innen und Institutionen

  • 1st Department of Lung Diseases, National Research Institute of Tuberculosis and Lung Diseases, 01-138 Warsaw, Poland.
  • Department of Radiology, National Research Institute of Tuberculosis and Lung Diseases, 01-138 Warsaw, Poland.
  • Department of Microbiology, National Research Institute of Tuberculosis and Lung Diseases, 01-138 Warsaw, Poland.
  • Department of Pathology, National Research Institute of Tuberculosis and Lung Diseases, 01-138 Warsaw, Poland.

ORCID-Profile: M Sobiecka, K Lewandowska

Zitieren

APA

Łyżwa, E., Sobiecka, M., Lewandowska, K., Siemion-Szcześniak, I., Barańska, I., Klatt, M., Langfort, R., Szturmowicz, M., & Tomkowski, W. (2023). Prolonged SARS-CoV-2 Infection and Organizing Pneumonia in a Patient with Follicular Lymphoma, Treated with Obinutuzumab—Challenging Recognition and Treatment. Viruses. https://doi.org/10.3390/v15030693

Vancouver

Łyżwa E, Sobiecka M, Lewandowska K, Siemion-Szcześniak I, Barańska I, Klatt M, et al. Prolonged SARS-CoV-2 Infection and Organizing Pneumonia in a Patient with Follicular Lymphoma, Treated with Obinutuzumab—Challenging Recognition and Treatment. Viruses. 2023. doi:10.3390/v15030693

BibTeX
@article{ywa2023,
  author = {Łyżwa, E and Sobiecka, M and Lewandowska, K and Siemion-Szcześniak, I and Barańska, I and Klatt, M and Langfort, R and Szturmowicz, M and Tomkowski, W},
  title = {Prolonged SARS-CoV-2 Infection and Organizing Pneumonia in a Patient with Follicular Lymphoma, Treated with Obinutuzumab—Challenging Recognition and Treatment},
  journal = {Viruses},
  year = {2023},
  doi = {10.3390/v15030693}
}
Kostenlos starten →